Epoximicin

50 µg

Proteasome inhibitor

Cell permeable, potent, and selective proteasome inhibitor. More potent than Lactocystin. Inhibits the chymotrypsin-like, trypsin-like, and peptidylglutamyl peptide-hydrolyzing activities of the proteasome. Meng L. et al., Epoxomicin, a potent and selective proteasome inhibitor, exhibits in-vivo antiinflammatory activity (1999), 96, 10403; Hanada M. et al., Epoxomicin, a new antitumor agent of microbial origin., J. Antibiot. (1992), 45, 1746.

Productnumber: S5308.0050

Source: synthetic

Technical Data: min. 95%, white solid substance, soluble in DMSO, insoluble in water; C28H50N4O7; MW = 554.7 g/mol.

Shipping/Storing-Information: shipped at RT, store at -20°C, keep tightly sealed. Protect from water.

Deutsche Produktseite:
Epoximicin 50 µg  Biochemicals

Matchcode: epoximicin epoxymicin epoximycin